Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.
The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.
The Institute of Cancer Research (ICR) is one of the world’s most influential cancer research institutes. Our mission is to make the discoveries that defeat cancer. We have a long and distinguished history of research with a major impact on the outcome for cancer patients. Our unique partnership with The Royal Marsden NHS Foundation Trust (RMH) makes us the largest comprehensive cancer centre in Europe, performing high quality original basic research and translational studies.
The Cancer Research UK Cancer Therapeutics Unit, within the Division of Cancer Therapeutics, is a multidisciplinary ‘bench to bedside’ centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer.
A Scientific Officer is required by the Drug Metabolism and Pharmacokinetics group to work alongside other members of the team on the pharmacology of new anticancer drugs. The successful candidate should have mass spectrometry experience with a desire to develop novel analytical methods to evaluate metabolic and pharmacokinetic properties of novel agents. Experience in instrument maintenance and troubleshooting is desirable. Ability to work flexibly to deliver to deadlines is essential.
This is an ideal opportunity for enthusiastic, committed analyst to make an important contribution to improved therapies for cancer patients, while gaining experience and training in drug discovery skills in an institute with a track record of success. Appointments will be for 2 years in the first instance.
To apply, please click on the Apply button below and follow the instructions.
In your application please indicate your notice period.
We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.